Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
SterileCare, Inc. holds a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently features 2 pending office actions. These actions are split between 2 distinct examiners and 2 distinct art units. MEDWAY, SCOTT J is the busiest examiner with 1 busiest examiner pending action. This indicates that each pending office action is being reviewed by a different examiner in a different art unit.
Practitioners must navigate 2 separate sets of art unit guidelines and 2 different examiner styles. The distribution of 2 pending office actions across 2 distinct examiners suggests that the portfolio's current filings cover diverse technical aspects within the Medical Devices & Mechanical Engineering field. Because there is no overlap in personnel or art units, the prosecution strategy for 1 action will not necessarily inform the other. Practitioners should focus on the individual records of the 2 distinct examiners to anticipate potential rejections. The presence of 2 distinct art units further implies that the subject matter of the 2 pending office actions is distinct enough to be classified into different examination groups.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| MEDWAY, SCOTT J | 1 | 66.7% | +23.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18112674 | COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | ARMSTRONG, SUSANNAH SIPPLE | 4d overdue |
| 18112648 | DISINFECTING CAP KIT FOR LUER ACCESS DEVICES | MEDWAY, SCOTT J | 35d |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18112674 | COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103 | Final Rejection | 4d overdue | Pending | Feb 22, 2023 |
| 18112648 | DISINFECTING CAP KIT FOR LUER ACCESS DEVICES | MEDWAY, SCOTT J | 3783 | §103 | Non-Final OA | 35d | Pending | Feb 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial